State Street Corporation 13D and 13G filings for Arrowhead Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-13 10:26 am Purchase | 2025-03-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR | STATE STREET CORP STT | 6,999,249 5.100% | 983,022 (+16.34%) | Filing |
| 2025-02-05 06:41 am Sale | 2024-12-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR | STATE STREET CORP STT | 6,016,227 4.800% | -338,104 (-5.32%) | Filing |
| 2024-10-16 09:15 am Sale | 2024-09-30 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR | STATE STREET CORP STT | 6,354,331 5.100% | -470,780 (-6.90%) | Filing |
| 2024-01-24 12:57 pm Purchase | 2023-12-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR | STATE STREET CORP STT | 6,825,111 6.350% | 854,767 (+14.32%) | Filing |
| 2023-02-08 10:08 am Purchase | 2022-12-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR | STATE STREET CORP STT | 5,970,344 5.630% | 1,845,874 (+44.75%) | Filing |